Mye Cancer Research Results

Mye, myelosuppression: Click to Expand ⟱
Source:
Type:

Myelosuppression — Suppression of bone-marrow hematopoietic activity resulting in reduced production of one or more blood-cell lineages. It commonly manifests as neutropenia, leukopenia, anemia, thrombocytopenia, or pancytopenia and is a frequent dose-limiting toxicity of cytotoxic chemotherapy and some targeted therapies.

Typical modulation: ↑ myelosuppression is generally unfavorable and indicates greater hematologic toxicity. ↓ myelosuppression is favorable when evaluating treatment tolerability or protective interventions.

Typical mechanistic relationship: Bone-marrow progenitor-cell injury or suppression → hematopoiesis ↓ → neutrophils / leukocytes / erythrocytes / platelets ↓ → infection, fatigue, bleeding, and treatment-delay risk ↑.



Scientific Papers found: Click to Expand⟱
9036- SP,    The efficacy of dietary Spirulina as an adjunct to chemotherapy to improve immune function and reduce myelosuppression in patients with malignant tumors
- Trial, Var, NA
Mye↓, CD8+↑, Imm↑, Dose↝,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Immune & Inflammatory Signaling(tgid=16) ⓘ

CD8+↑, 1,   Imm↑, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

Dose↝, 1,  

Clinical Biomarkers(tgid=22) ⓘ

Mye↓, 1,  
Total Targets: 4

Pathway results for Effect on Normal Cells:


Total Targets: 0

Scientific Paper Hit Count for: Mye, myelosuppression
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:0  prod#:%  Target#:1914  State#:%  Dir#:1
wNotes=0 sortOrder:rid,rpid

 

Home Page